Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly

Mise à jour : Il y a 4 ans
Référence : NCT01013675

Femme et Homme

Extrait

A controlled, double-blind study to determine the immunogenicity and safety of influenza cell derived vaccine in elderly subjects.


Critère d'inclusion

  • Influenza Vaccines

Liens